Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Kabasura Kudineer: 60 ml bd for 14 days
Control Intervention1: Vitamin C, Zinc supplementation: Vitamin C - 60000IU OD for 14 days
Zinc supplementation - 100mg od for 14 days
Sponsors
Dean
Central Council for Research in Siddha
Eligibility
Inclusion criteria
Inclusion criteria: 1.Laboratory confirmed COVID-19 without symptoms 2.Consenting to participate in the study and sign the informed consent
Exclusion criteria
Exclusion criteria: 1.Patient with co morbid conditions like DM, HT, BA 2.Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19 3.Pregnant and mothers, those who have a pregnancy plan. 4.Patients with other systemic malignant diseases such as malignant tumors, mental illnesses, etc., which the researchers consider unsuitable for participation in the study 5.People who have been allergic to Siddha medicine or intolerant to taking medicine 6.Patients participating in other COVID-19 clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in incidence of clinical symptoms of COVID 19 Negative conversion of SARS-CoV-2 Reduction in Viral load of SARS-CoV-2 at the end of treatment Examine the levels immune markers and inflammatory markersTimepoint: 14 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of in hospital time adverse events/effects Siddha Udaliyal assessment Siddha Uyir thathukkal and udal thathukkal assessmentTimepoint: 14 days | — |
Countries
India
Contacts
Public ContactDr C Anbarasi
Siddha Central Research Institute
Outcome results
None listed